Free Trial

Trinity Biotech (TRIB) Short Interest Ratio & Short Volume

Trinity Biotech logo
$1.30 -0.02 (-1.52%)
(As of 11/20/2024 ET)

Trinity Biotech Short Interest Data

Trinity Biotech (TRIB) has a short interest of 94,100 shares, representing 0.86% of the float (the number of shares available for trading by the public). This marks a -23.06% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 165,690 shares to cover all short positions.

Current Short Interest
94,100 shares
Previous Short Interest
122,300 shares
Change Vs. Previous Month
-23.06%
Dollar Volume Sold Short
$165,616.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
7,620,000 shares
Float Size
10,960,000 shares
Short Percent of Float
0.86%
Today's Trading Volume
44,771 shares
Average Trading Volume
165,690 shares
Today's Volume Vs. Average
27%
Short Selling Trinity Biotech?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Trinity Biotech and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

TRIB Short Interest Over Time

TRIB Days to Cover Over Time

TRIB Percentage of Float Shorted Over Time

Trinity Biotech Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202494,100 shares $165,616.00 -23.1%0.9%0.1 $1.76
10/15/2024122,300 shares $205,720.83 +22.3%1.1%0.1 $1.68
9/30/2024100,000 shares $110,000.00 +11.5%0.9%0.1 $1.10
9/15/202489,700 shares $143,520.00 -57.9%0.8%0.1 $1.60
8/31/2024213,200 shares $424,268.00 +1,232.5%1.8%0.2 $1.99
8/15/202416,000 shares $36,800.00 -25.6%0.2%0.3 $2.30
7/31/202421,500 shares $64,070.00 +16.9%0.3%0.4 $2.98
7/15/202418,400 shares $56,304.00 +70.4%0.3%0.4 $3.06
6/30/202410,800 shares $23,004.00 -71.5%0.2%0.2 $2.13
6/15/202437,900 shares $105,362.00 +213.2%0.5%0.9 $2.78
5/31/202412,100 shares $20,328.00 +63.5%0.2%0.5 $1.68
5/15/20247,400 shares $11,248.00 +516.7%0.1%0.4 $1.52
4/30/20241,200 shares $2,184.00 -36.8%0.0%0.1 $1.82
4/15/20241,900 shares $3,629.00 +58.3%0.0%0 $1.91
3/31/20241,200 shares $2,448.00 -72.1%0.0%0 $2.04
3/15/20244,300 shares $9,718.00 -71.9%0.1%0 $2.26
2/29/202415,300 shares $33,354.00 -5.0%0.2%0.2 $2.18
2/15/202416,100 shares $41,135.50 -46.9%N/A0.2 $2.56
1/31/202430,300 shares $17,877.00 +3.1%N/A0.1 $0.59
1/15/202429,400 shares $14,112.00 +92.2%N/A0.6 $0.48
12/31/202315,300 shares $6,563.70 -72.6%N/A0.3 $0.43
12/15/202355,800 shares $27,844.20 -14.6%N/A1.2 $0.50
11/30/202365,300 shares $31,148.10 +9.4%N/A1.8 $0.48
11/15/202359,700 shares $25,611.30 +70.1%N/A2.2 $0.43
10/31/202335,100 shares $16,146.00 +9.4%N/A1.3 $0.46
10/15/202332,100 shares $16,820.40 +23.0%N/A0.8 $0.52
9/30/202326,100 shares $19,186.11 +6.1%N/A0.6 $0.74
9/15/202324,600 shares $17,736.60 -1.6%N/A0.4 $0.72
8/31/202325,000 shares $20,000.00 +20.2%N/A0.4 $0.80
8/15/202320,800 shares $14,913.60 -59.9%N/A0.3 $0.72
7/31/202351,800 shares $49,210.00 +3.2%N/A0.8 $0.95
7/15/202350,200 shares $42,670.00 +27.4%N/A0.8 $0.85
6/30/202339,400 shares $37,473.34 -8.4%N/A0.8 $0.95
6/15/202343,000 shares $44,720.00 +91.1%N/A1 $1.04
5/31/202322,500 shares $20,925.00 -23.5%N/A0.5 $0.93
5/15/202329,400 shares $27,606.60 -18.3%N/A0.8 $0.94
4/30/202336,000 shares $37,972.80 -6.7%N/A1.1 $1.05
4/15/202338,600 shares $32,427.86 +33.1%N/A1.3 $0.84
3/31/202329,000 shares $27,260.00 -23.1%N/A1.2 $0.94
3/15/202337,700 shares $36,188.23 +10.9%N/A1.5 $0.96
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
2/28/202334,000 shares $35,870.00 -11.9%N/A1.3 $1.06
2/15/202338,600 shares $41,109.00 -1.5%N/A1.5 $1.07
1/31/202339,200 shares $42,140.00 -35.3%N/A1.3 $1.08
1/15/202360,600 shares $64,236.00 -19.8%N/A1.8 $1.06
12/30/202275,600 shares $74,844.00 -5.4%N/A2.3 $0.99
12/15/202279,900 shares $92,684.00 -23.8%N/A2.4 $1.16
11/30/2022104,900 shares $139,517.00 -22.0%N/A3.2 $1.33
11/15/2022134,400 shares $178,752.00 -2.9%N/A3.7 $1.33
10/31/2022138,400 shares $160,544.00 -17.1%N/A4.2 $1.16
10/15/2022166,900 shares $198,627.69 -12.7%N/A4.7 $1.19
9/30/2022191,200 shares $204,775.20 -12.1%N/A5.2 $1.07
9/15/2022217,400 shares $256,532.00 -13.9%N/A5.3 $1.18
8/31/2022252,500 shares $308,050.00 -13.4%N/A5.8 $1.22
8/15/2022291,700 shares $402,546.00 -19.6%N/A6.1 $1.38
7/31/2022362,800 shares $493,408.00 -19.8%N/A5.9 $1.36
7/15/2022452,600 shares $624,588.00 +1.0%N/A4.7 $1.38
6/30/2022448,100 shares $551,163.00 -6.4%N/A0.7 $1.23
6/15/2022478,700 shares $588,801.00 +2.9%N/A0.7 $1.23
5/31/2022465,100 shares $660,442.00 +10.6%N/A0.7 $1.42
5/15/2022420,600 shares $492,102.00 +1.8%N/A0.6 $1.17
4/30/2022413,100 shares $491,589.00 -34.1%N/A0.6 $1.19
4/15/2022626,900 shares $764,818.00 +246.0%N/A0.9 $1.22
3/31/2022181,200 shares $192,072.00 -23.2%N/A1.4 $1.06
3/15/2022235,800 shares $231,060.42 +6.5%N/A1.8 $0.98
2/28/2022221,400 shares $225,828.00 +32.1%N/A1.5 $1.02
2/15/2022167,600 shares $191,064.00 -20.2%N/A1.2 $1.14
1/31/2022210,100 shares $241,615.00 -73.4%N/A1.8 $1.15
1/15/2022790,500 shares $1.09 million +36.5%N/A7.2 $1.39
12/31/2021579,200 shares $828,256.00 +103.8%N/A5.4 $1.43
12/15/2021284,200 shares $477,456.00 -7.3%N/A2.6 $1.68
11/30/2021306,400 shares $566,840.00 +4.2%N/A2.8 $1.85
11/15/2021294,000 shares $585,060.00 -9.4%N/A2.6 $1.99
10/29/2021324,600 shares $668,676.00 +10.5%N/A2.5 $2.06
10/15/2021293,900 shares $596,617.00 +5.2%N/A1.8 $2.03
9/30/2021279,300 shares $603,288.00 +0.0%N/A1.3 $2.16
9/15/2021279,200 shares $664,496.00 -14.9%N/A1.4 $2.38
8/31/2021327,900 shares $855,819.00 +23.4%N/A1.6 $2.61
8/13/2021265,700 shares $581,883.00 -0.2%N/A1.4 $2.19
7/30/2021266,300 shares $583,197.00 +4.6%1.3%1 $2.19
7/15/2021254,500 shares $521,725.00 -10.1%1.2%1 $2.05
6/30/2021283,200 shares $832,608.00 -1.9%1.4%1.3 $2.94
6/15/2021288,800 shares $901,056.00 -13.7%1.4%1 $3.12
5/28/2021334,700 shares $1.05 million +19.7%1.6%1.1 $3.13
5/14/2021279,600 shares $939,456.00 -18.0%1.4%0.8 $3.36
4/30/2021340,900 shares $1.17 million -17.7%1.7%1.1 $3.43
4/15/2021414,200 shares $1.61 million +13.5%2.0%0.8 $3.88
3/31/2021364,900 shares $1.44 million -3.0%1.8%0.7 $3.95
3/15/2021376,300 shares $1.73 million +45.8%1.8%0.8 $4.61
2/26/2021258,100 shares $1.36 million +59.1%N/A0.6 $5.28
2/12/2021162,200 shares $981,310.00 +22.0%0.8%0.3 $6.05
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
1/29/2021133,000 shares $573,230.00 +4.7%N/A0.3 $4.31
1/15/2021127,000 shares $514,350.00 -15.3%N/A0.4 $4.05
12/31/2020150,000 shares $582,000.00 +32.4%N/A0.5 $3.88
12/15/2020113,300 shares $491,722.00 +0.7%N/A0.4 $4.34
11/30/2020112,500 shares $497,250.00 +72.0%N/A0.3 $4.42
11/15/202065,400 shares $197,508.00 +15.8%N/A0.2 $3.02
10/30/202056,500 shares $155,940.00 +52.7%N/A0.1 $2.76
10/15/202037,000 shares $96,570.00 +56.8%N/A0.1 $2.61
9/30/202023,600 shares $47,672.00 -62.1%N/A0 $2.02
9/15/202062,300 shares $141,421.00 -54.4%N/A0.1 $2.27
8/31/2020136,700 shares $263,831.00 -75.6%N/A0.2 $1.93
8/14/2020560,200 shares $1.28 million -0.7%N/A0.5 $2.28
7/31/2020564,400 shares $1.41 million -12.6%N/A0.6 $2.49
7/15/2020646,000 shares $1.64 million -2.2%N/A0.7 $2.54
6/30/2020660,700 shares $1.44 million -5.6%N/A0.7 $2.18
6/15/2020699,700 shares $1.36 million +14.4%N/A0.7 $1.95
5/29/2020611,500 shares $776,605.00 -3.0%N/A0.7 $1.27
5/15/2020630,300 shares $945,450.00 +25.4%N/A0.6 $1.50
4/30/2020502,800 shares $799,452.00 +130.4%N/A0.6 $1.59
4/15/2020218,200 shares $235,656.00 +75.3%N/A0.3 $1.08
3/31/2020124,500 shares $170,565.00 -35.7%N/A0.2 $1.37
3/13/2020193,500 shares $179,955.00 +10.8%N/A0.1 $0.93
2/28/2020174,700 shares $122,290.00 +24.0%N/A0.4 $0.70
2/14/2020140,900 shares $142,309.00 +4.5%N/A1 $1.01
1/31/2020134,900 shares $128,155.00 +12.4%N/A1.1 $0.95
1/15/2020120,000 shares $132,000.00 +1.7%N/A1.3 $1.10
12/31/2019118,000 shares $146,320.00 -3.5%N/A1.7 $1.24

TRIB Short Interest - Frequently Asked Questions

What is Trinity Biotech's current short interest?

Short interest is the volume of Trinity Biotech shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 94,100 shares of TRIB short. 0.86% of Trinity Biotech's shares are currently sold short. Learn More on Trinity Biotech's current short interest.

What is a good short interest percentage for Trinity Biotech?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.86% of Trinity Biotech's floating shares are currently sold short.

Is Trinity Biotech's short interest increasing or decreasing?

Trinity Biotech saw a decrease in short interest in the month of October. As of October 31st, there was short interest totaling 94,100 shares, a decrease of 23.1% from the previous total of 122,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Trinity Biotech's float size?

Trinity Biotech currently has issued a total of 7,620,000 shares. Some of Trinity Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Trinity Biotech currently has a public float of 10,960,000 shares.

How does Trinity Biotech's short interest compare to its competitors?

0.86% of Trinity Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Trinity Biotech: Anebulo Pharmaceuticals, Inc. (0.12%), LAVA Therapeutics (0.13%), RAPT Therapeutics, Inc. (7.64%), CERo Therapeutics Holdings, Inc. (3.91%), Lumos Pharma, Inc. (1.54%), NextCure, Inc. (0.31%), OKYO Pharma Limited (1.11%), Carisma Therapeutics, Inc. (4.00%), HCW Biologics Inc. (0.04%), Barinthus Biotherapeutics plc (0.02%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Trinity Biotech stock?

Short selling TRIB is an investing strategy that aims to generate trading profit from Trinity Biotech as its price is falling. TRIB shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Trinity Biotech?

A short squeeze for Trinity Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TRIB, which in turn drives the price of the stock up even further.

How often is Trinity Biotech's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TRIB, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:TRIB) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners